San Diego-based Trovagene Inc. (Nasdaq: TROV), a developer of transrenal molecular diagnostics, announced Monday that Dr. Paul Billings has joined the company's scientific advisory board.
Billings currently serves as chief medical officer at Life Technologies Corp. (Nasdaq: LIFE). He is also a certified internist and clinical geneticist, and he brings expertise and clinical experience in the areas of genomics and molecular medicine.
“We are honored that Dr. Billings will be collaborating with Trovagene,” said Antonius Schuh, chief executive officer of Trovagene. “He specializes in improving patient care through expanding the use of medically relevant genomic technologies in clinical settings and his expertise is critical he helps shape policy in the rapidly evolving field of genomic medicine.”